Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Cefprozil Granules

Approval Number

国药准字H20052697

Company哈尔滨凯程制药有限公司

Registration Date

May 25, 2021

Previous Approval Numbers

国药准字H20052697

Drug Information

Generic Name

头孢丙烯颗粒

Trade Name

凯可之

Brand Name

凯可之

Dosage Form

颗粒剂

Strength

按C18H19N3O5S计0.125g

Drug Type

化学药品

Registration Date

May 25, 2021

Company Information

Applicant Company

Company Name哈尔滨凯程制药有限公司

Company Address

黑龙江省哈尔滨市呼兰区利民开发区北京路

Manufacturing Company

Company Name哈尔滨凯程制药有限公司

Company Address

黑龙江省哈尔滨市呼兰区利民开发区北京路

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy